Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.

Proniosomes refer to a flexible vesicular carrier with the potential for drug administration through the transdermal route. A proniosome gel type transdermal delivery system of Atenolol was prepared and extensively studied both in vitro drug release and ex vivo permeation studies. The prepared formulations were evaluated for vesicle size, entrapment efficiency, in vitro drug loading, and drug release studies. The release of drug had shown considerable improvement in controlled manner from the prepared gel formulation. It was observed that Span 40 & 60 (A 8) based formulations shows vesicles of minimum size and higher entrapment efficiency compared to the other formulations. Proniosomal transdermal therapeutic system (A 8) was found to be the optimized formulation as it possess good drug release and shows permeation in a steady-state manner over a desired period of time. Also the drug diffusion across snake sheded skin, guinea pig abdomen skin, albino rat, porcine ear correlates better with in vitro drug release studies. The formulation was found to be stable when stored at room temperature and at refrigeration temperature (4 ± 2°C) for 90 days.

[1]  A. Ram,et al.  NON-IONIC PROVESICULAR DRUG CARRIER: AN OVERVIEW , 2013 .

[2]  Omar K. Shoukry,et al.  Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  A. ElMeshad,et al.  Comparative Study on the Effects of Some Polyoxyethylene Alkyl Ether and Sorbitan Fatty Acid Ester Surfactants on the Performance of Transdermal Carvedilol Proniosomal Gel Using Experimental Design , 2010, AAPS PharmSciTech.

[4]  K. Srikanth,et al.  Proniosomes: A Novel Drug Carrier System , 2010 .

[5]  V. Sankar,et al.  Formulation and Optimization of Zidovudine Niosomes , 2010, AAPS PharmSciTech.

[6]  V. Gajbhiye,et al.  Enhanced Oral Bioavailability of Griseofulvin via Niosomes , 2009, AAPS PharmSciTech.

[7]  Hatem Fessi,et al.  Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. , 2009, European journal of dermatology : EJD.

[8]  M. Jug,et al.  Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol , 2009, Drug development and industrial pharmacy.

[9]  M. Anwer,et al.  Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation , 2009, Journal of drug targeting.

[10]  Ra,et al.  Proniosome based drug delivery system of piroxicam , 2008 .

[11]  O. Sammour,et al.  Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.

[12]  T. Baykara,et al.  In vitro and in vivo transdermal studies of atenolol using iontophoresis. , 2008, Acta poloniae pharmaceutica.

[13]  Biana Godin,et al.  Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. , 2007, Advanced drug delivery reviews.

[14]  Ankur Gupta,et al.  Design and Development of a Proniosomal Transdermal Drug Delivery System for Captopril , 2007 .

[15]  A. Fadda,et al.  Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. , 2006, International journal of pharmaceutics.

[16]  Sang-Chul Shin,et al.  Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  R. Umamaheswari,et al.  Protransfersomes For Effective Transdermal Delivery Of Norgestrel Preparation And In Vitro Characterization , 2003 .

[18]  A. Fadda,et al.  Niosomes as carriers for tretinoin. I. Preparation and properties. , 2002, International journal of pharmaceutics.

[19]  J. Fang,et al.  In vitro skin permeation of estradiol from various proniosome formulations. , 2001, International journal of pharmaceutics.

[20]  N. Udupa,et al.  Formulation and Evaluation Of Nimesulide Transdermal Drug Delivery Systems , 2000 .

[21]  D. Rhodes,et al.  Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.

[22]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[23]  Ramesh Transdermal delivery of drugs , 1997 .

[24]  Indra K. Reddy,et al.  Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology , 1997 .

[25]  R. J. Harwood Transdermal delivery of drugs , 1988 .

[26]  R. Shanks,et al.  Clinical pharmacologic observations on atenolol, a beta‐adrenoceptor blocker , 1976, Clinical pharmacology and therapeutics.